Total body irradiation for patients before stem cell transplants
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
This study looks at how total body irradiation before stem cell transplants affects patients to see how well it works and how they tolerate it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | European Institute of Oncology Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Milan) |
| Trial ID | NCT06335277 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients undergoing total body irradiation (TBI) as part of their preparation for bone marrow or peripheral stem cell transplantation. TBI is utilized to suppress the immune system and eliminate remaining cancer cells after chemotherapy. The study aims to collect and analyze data from these treatments to improve understanding of their effectiveness and tolerance. By gathering information from a diverse patient population, the research seeks to identify optimal treatment parameters and clinical situations that enhance patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are patients who are set to receive total body irradiation as part of their treatment for leukemia, lymphoma, or aplastic anemia.
Not a fit: Patients who are not undergoing total body irradiation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment protocols for patients undergoing stem cell transplants, enhancing their chances of recovery.
How similar studies have performed: While TBI has been a standard treatment for many years, this study aims to refine its application and effectiveness, contributing to ongoing research in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients undergoing total body irradiation as candidates for bone marrow or peripheral stem cell transplantation. 2. Signed informed consent Exclusion Criteria: * Patients who do not undergo total body irradiation
Where this trial is running
Milan
- European Institute of Oncology — Milan, Italy (Recruiting)
Study contacts
- Principal investigator: Barbara Alicja Jereczek — European Institute of Oncology
- Study coordinator: Barbara Alicja Jereczek
- Email: barbara.jereczek@ieo.it
- Phone: +39 02 57489326
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.